Table 2.

Clinical and lung function parameters associated with OS in multivariate Cox regression analysis after conditioning using BEAM or high-dose melphalan

VariablesBEAMHigh-dose melphalan
Patients, nHR (95% CI)PPatients, nHR (95% CI)P
DLCOcSB ≤ 60 % of predicted 37 2.47 (1.47-4.13) .001 31 1.74 (0.92-3.28) .08 
Age > 70 y 23 2.13 (1.07-4.22) .03 126* 2.05 (1.28-3.26)* .003* 
KPS ≤ 80% 89 1.89 (1.20-2.97) .005 109 1.28 (0.81-2.03) .28 
HCT-CI score ≥ 4 137 1.46 (0.94-2.28) .09 56 2.11 (1.26-3.53) .004 
Progressive disease status prior to auto-HSCT 28 7.18 (4.14-12.4) .001 18 1.07 (0.46-2.50) .88 
VariablesBEAMHigh-dose melphalan
Patients, nHR (95% CI)PPatients, nHR (95% CI)P
DLCOcSB ≤ 60 % of predicted 37 2.47 (1.47-4.13) .001 31 1.74 (0.92-3.28) .08 
Age > 70 y 23 2.13 (1.07-4.22) .03 126* 2.05 (1.28-3.26)* .003* 
KPS ≤ 80% 89 1.89 (1.20-2.97) .005 109 1.28 (0.81-2.03) .28 
HCT-CI score ≥ 4 137 1.46 (0.94-2.28) .09 56 2.11 (1.26-3.53) .004 
Progressive disease status prior to auto-HSCT 28 7.18 (4.14-12.4) .001 18 1.07 (0.46-2.50) .88 

Multivariate analysis was performed with the Cox proportional-hazards regression model using parameters influencing outcome and DLCOcSB ≤ 60% of predicted as hypothesis covariate.

*

Age > 60 years.

or Create an Account

Close Modal
Close Modal